-
SCD1 Deficiency Primes Chicken Cells for Ferroptosis
2026-09-30
This study shows that stearoyl-CoA desaturase 1 (SCD1) protects chicken embryonic liver cells from ferroptosis by coordinating lipid storage, antioxidant defenses, iron balance, and mitochondrial integrity. Its loss increased lipid peroxidation and ferroptosis-associated injury, whereas SCD1 overexpression produced a more resistant cellular state, providing a mechanistic framework for studying avian liver homeostasis.
-
Defactinib FAK Phosphorylation Workflow
2026-09-30
Defactinib enables a target-engagement workflow that connects FAK Tyr397 signaling with cancer-cell phenotypes and paclitaxel response. This guide combines dose-response testing, phosphoprotein validation, combination analysis, and phosphoproteomic thinking for more defensible cancer therapy research.
-
Ferrostatins, Lipid Peroxidation, and Cell Death
2026-09-29
Skouta and colleagues showed that ferrostatin-1 protects cells by interrupting oxidative lipid damage, rather than by broadly suppressing all reactive oxygen species. By testing ferrostatin-1 across Huntington’s disease, periventricular leukomalacia, kidney dysfunction, and cancer-cell models, the study established a mechanistic framework for ferrostatin design and for interpreting lipid peroxidation in disease biology.
-
Trolox as a Translational Redox Benchmark
2026-09-29
Trolox is more than a routine antioxidant control. This thought-leadership guide explains how its redox chemistry, membrane-protective activity, and assay standardization value can strengthen oxidative injury research, neurodegeneration studies, cancer biology research, and high-throughput antioxidant screening. It also connects Trolox benchmarking with a recent immobilized-microalgae study, showing how antioxidant measurements can inform translation into biomaterials while clarifying the limits of cross-domain inference.
-
Berberine, RXRα/PPARγ, and Atherosclerotic SASP
2026-09-28
A 2025 study identifies an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and ApoE−/− atherosclerosis models. Its combination of disease modeling, Smart-seq analysis, and macrophage-specific RXRα knockdown provides a mechanistic framework for studying how nuclear-receptor signaling controls inflammatory aging in plaques.
-
MnTBAP Chloride and Brain Redox Causality
2026-09-28
Explore how MnTBAP Chloride can help interrogate the links among mitochondrial redox imbalance, inflammation, and stress-related behavior. This article unpacks a chronic-stress rat study and turns its findings into practical guidance for designing more informative preclinical experiments.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-27
Saito and colleagues report a direct 3D cluster-culture approach for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids can be cryopreserved and differentiated as monolayers into intestinal epithelial cells with drug-metabolizing enzyme and transporter activities, providing a promising human-relevant platform for pharmacokinetic studies that still requires assay-specific validation.
-
Ertapenem Sodium Salt: Research and Resistance
2026-09-26
Ertapenem sodium salt is a broad-spectrum carbapenem antibiotic whose PBP-binding mechanism makes it relevant to bacterial susceptibility and antibiotic resistance research. This article distinguishes the product’s reported properties from findings in a recent carbapenem-resistant Enterobacter cloacae surveillance study, which did not establish ertapenem-specific susceptibility.
-
(S)-Mephenytoin in Organoid PK Assays
2026-09-25
Use (S)-Mephenytoin to probe CYP2C19-dependent oxidative metabolism while human iPSC-derived intestinal models add a relevant epithelial context. The workflow distinguishes what organoid studies have established from what must still be validated specifically for CYP2C19.
-
GLT-1 and CB1–CREB Signaling After Traumatic Brain Injury
2026-09-25
A controlled cortical impact study links an early decline in astrocytic GLT-1 to 2-AG/CB1–CREB signaling after traumatic brain injury. The findings suggest that preserving GLT-1-dependent glutamate clearance may reduce neuronal apoptosis and cognitive deficits, while highlighting the need for further cell-specific and translational validation.
-
MK-5108 (VX-689): Reliable Cell Assays
2026-09-24
A practical guide to using MK-5108 (VX-689), SKU A4120, in cell-cycle, viability, and proliferation experiments. It explains how to interpret biochemical potency, control DMSO and solubility, and connect assay results to Aurora A research without overreading the evidence.
-
Nanobody-TurboID Maps the CD38-Associated Surfaceome
2026-09-24
The study introduces nanobody-targeted TurboID (NBID) to profile proteins near CD38 on living-cell surfaces, identifying adhesion, extracellular-matrix, and membrane-domain networks in A549 and THP-1 cells. Its findings connect CD38-proximal cadherin complexes with tumor-cell transendothelial migration and establish a proximity-labeling strategy for studying native cell-surface protein neighborhoods.
-
Caveolin-1, Cholesterol Homeostasis, and MASLD
2026-09-23
A 2025 study links declining hepatic caveolin-1 (CAV1) with cholesterol accumulation, endoplasmic reticulum stress, and pyroptosis during MASLD progression. Using mouse, human-sample, transcriptomic, and cell-based approaches, the authors identify an FXR/NR1H4–ABCG5/ABCG8 pathway that may connect CAV1 to cholesterol homeostasis and liver injury.
-
Hexetidine: Designing Better Oral Assays
2026-09-23
Hexetidine (NSC-17764) is more than a broad-spectrum antimicrobial: its assay behavior depends on strain, matrix, exposure time, and combination effects. This evidence-led guide shows how to interpret MIC, biofilm, saliva-persistence, and copper-synergy data without overstating clinical relevance.
-
Fluorouracil: From TS Stress to CSC Assays
2026-09-22
Fluorouracil research becomes more informative when thymidylate synthase inhibition is measured alongside replication stress and cancer stem cell state. This guide connects 5-Fluorouracil assay design with TAK1-YAP biology while clearly separating established evidence from testable hypotheses.